文献速递脑血管病外科神经重症

后部可逆性脑病综合征作为蛛网膜下腔出血诱导性高血压治疗的并发症:病例对照研究

Posterior Reversible Encephalopathy Syndrome as a Complication of Induced Hypertension in Subarachnoid Hemorrhage: A Case-Control Study.
PubMed 文献 · Neurosurgery · 2019-01-01

本研究从345例蛛网膜下腔出血患者中识别出68例接受诱导性高血压治疗者,其中5例(7%)诊断为后部可逆性脑病综合征(PRES),中位发生于升压药启动后6.6天。PRES组诱导前平均动脉压(112 vs 90 mm Hg)和最高目标平均动脉压(140 vs 120 mm Hg)均高于对照组(均P<.01),平均动脉压升高幅度更大(54 vs 34,P=.004)。4例存活PRES患者停用诱导性高血压后完全缓解。

要点

  • 诱导性高血压治疗的蛛网膜下腔出血患者中7%诊断为PRES,中位发生于升压药启动后6.6天。
  • PRES组诱导前平均动脉压112 vs 对照组90 mm Hg,最高目标平均动脉压140 vs 120 mm Hg,均P<.01。
  • PRES组平均动脉压升高幅度54 vs 对照组34(P=.004),4例存活者停用诱导性高血压后完全缓解。

核心结论

  • 接受诱导性高血压治疗的蛛网膜下腔出血患者中7%诊断为PRES,多发生于平均动脉压被升至远高于基线、超过传统自动调节阈值时。
  • 在积极诱导性高血压治疗期间出现无法解释的神经功能恶化时,似应高度怀疑这一可逆性疾病。

研究设计与样本

  • 病例对照研究,从3年期间的345例蛛网膜下腔出血患者中识别出68例接受诱导性高血压治疗者。
  • PRES基于临床怀疑诊断并经影像学确认,比较PRES病例与诱导性高血压治疗对照者的诱导性高血压相关数据。

主要发现

  • 5例诊断为PRES,中位发生于升压药启动后6.6天(范围1-8天)。
  • 所有PRES患者均表现为嗜睡,3例有新发局灶性缺损,1例有癫痫发作。
  • 基线平均动脉压(迟发性脑缺血前)在病例与对照间无差异,但诱导性高血压前即刻平均动脉压(112 vs 90)和最高目标平均动脉压(140 vs 120 mm Hg)均更高(均P<.01)。
  • 平均动脉压升高幅度更大(高于基线54 vs 34,P=.004),而诱导性高血压程度无差异(高于诱导前平均动脉压37 vs 38)。
  • 4例存活PRES患者停用诱导性高血压后均完全缓解。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Induced hypertension (IH) remains the mainstay of medical management for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH). However, raising blood pressure above normal levels may be associated with systemic and neurological complications, of which posterior reversible encephalopathy syndrome (PRES) has been increasingly recognized. OBJECTIVE: To ascertain the frequency and predisposing factors for PRES during IH therapy. METHODS: We identified 68 patients treated with IH from 345 SAH patients over a 3-yr period. PRES was diagnosed based on clinical suspicion, confirmed by imaging. We extracted additional data on IH, including baseline and highest target mean arterial pressure (MAP), comparing PRES to IH-treated controls. RESULTS: Five patients were diagnosed with PRES at median 6.6 d (range 1-8 d) from vasopressor initiation. All presented with lethargy, 3 had new focal deficits, and 1 had a seizure. Although baseline MAP (prior to DCI) did not differ between cases and controls, both MAP immediately prior to IH (112 vs 90) and highest MAP targeted were greater (140 vs 120 mm Hg, both P < .01). Magnitude of MAP elevation was greater (54 vs 34 above baseline, P = .004) while degree of IH was not (37 vs 38 above pre-IH MAP). All 4 surviving PRES patients had complete resolution with IH discontinuation. CONCLUSION: PRES was diagnosed in 7% of SAH patients undergoing IH therapy, most often when MAP was raised well above baseline to levels that exceed traditional autoregulatory thresholds. High suspicion for this reversible disorder appears warranted in the face of unexplained neurological deterioration during aggressive IH.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Allen ML, Kulik T, Keyrouz SG, et al. Posterior Reversible Encephalopathy Syndrome as a Complication of Induced Hypertension in Subarachnoid Hemorrhage: A Case-Control Study. Neurosurgery. 2019. PMID: 29889274. doi:10.1093/neuros/nyy240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。